Press release
07.04.2021 To the attention of interested persons AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual […]
Press release
31.03.2021 To the attention of interested persons AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues […]
Press release
25.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood […]
Important notification
25.03.2021 To the attention of interested persons As announced in the Commission BREXIT Notice on medicines in January this year, […]
Press release
22.03.2021 To the attention of interested persons EMA press release: EMA advises against use of ivermectin for the prevention or […]
Press release
18.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible […]
Press release
15.03.2021 To the attention of interested persons EMA press release: Review of thalassaemia medicine Zynteglo started. download document …
Press release
15.03.2021 To the attention of interested persons EMA press release: EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and […]
Press release
11.03.2021 To the attention of interested persons EMA press release: EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU. […]
Press release
11.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine Janssen (COVID-19 vaccine (Ad26.COV2-S [recombinant])). download document …